RT Journal Article
SR Electronic
A1 Zarifyan, Alla
T1 Solitaire Stent Reduced Disability in Stroke Patients in the SWIFT PRIME Trial
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 2
SP 15
OP 16
DO 10.1177/1559897715578114
UL http://mdc.sagepub.com/content/15/2/15.abstract
AB The SWIFT PRIME study demonstrated that the Solitaire stent was safe and effective at reducing poststroke disability in patients with acute ischemic stroke. Functional independence (mRS of 0 to 2) at 90 days was achieved in 60.2% of patients in the Solitaire plus IV tPA group vs 35.5% in the IV tPA group (P < .0008).